PamCis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PamCis, covering 2012-06-20 to 2012-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers [Phase 2]